I am the Director of Corporate Communications and ESG for SERB Pharmaceuticals, global specialty pharma company with a growing portfolio of medicines for emergency care and rare diseases. SERB has the broadest antidote portfolio in the world, including medical countermeasures for chemical, biological, radiological and nuclear (CBRN) risks. I lead proactive public relations and internal communication programs that help people understand SERB’s business, growth strategy, and culture. I’m passionate about telling stories, building relationships, and strengthening organisations. I believe science and technology have the potential to transform the practice of medicine and to make a real difference for patients. My 20 years of experience in healthcare communications spans corporate, financial, internal, and product communications at global pharmaceutical and medical device companies.More recently, I have taken on responsiblity for the company's ESG strategy. In line with the company's purpose, vision and values, SERB is committed to being a sustainable and responsible company. We're working to ensure we deliver on our vision via sustainable business practices, implemented ethically and respectful of diversity.